Table 1.
Baseline characteristics of patients in the DURATION‐3 RCT (adapted from Reference 17)
| Characteristic | Exenatide once weekly (n = 233) | Insulin glargine (n = 223) |
|---|---|---|
| Women [n (%)] | 113 (48%) | 100 (45%) |
| Ethnic origin [n (%)] | ||
| African American | 1 (1%) | 1 (<1%) |
| White | 190 (82%) | 189 (85%) |
| Asian | 13 (6%) | 14 (6%) |
| Hispanic | 28 (12%) | 19 (9%) |
| Age (years) [mean (SD)] | 58 (10) | 58 (9) |
| Weight (kg) [mean (SD)] | 91.2 (18.6) | 90.6 (16.4) |
| Haemoglobin A1C (%) [n (%)] | 8.3% (1.1%) | 8.3% (1.0%) |
| Body‐mass index (kg/m2) [mean (SD)] | 32 (5.0) | 32 (5.0) |
| Fasting blood glucose (mmol/L) [mean (SD)] | 9.9 (2.5) | 9.7 (2.7) |
| Duration of diabetes (years) [mean (SD)] | 8.0 (6.0) | 7.8 (6.0) |
| Background treatment [n (%)] | ||
| Metformin | 164 (70%) | 157 (70%) |
| Metformin and sulfonylurea | 69 (30%) | 66 (30%) |